Suchergebnisse - "olaparib"

PubPharm (2.272)

1

CRABP2 reduces the sensitivity of Olaparib in ovarian cancer by downregulating Caspase-8 and decreasing the production of reactive oxygen species

enthalten in: Chemico-biological interactions | 2024

von Zeng, S. | Xu, Z. | Liu, Y. | +2

2

Case report : Emerging BRCA mutation confers benefit from olaparib after chemotherapy intolerance in advanced triple-negative breast cancer

enthalten in: Clinical case reports | 2024

von Shen, X. | Wu, J. | Li, J. | +2

3

FSP1 inhibition enhances olaparib sensitivity in BRCA-proficient ovarian cancer patients via a nonferroptosis mechanism

enthalten in: Cell death and differentiation | 2024

von Miao, H. | Meng, H. | Zhang, Y. | +3

4

Interstitial lung disease with prolonged fever that occurred during long-term administration of olaparib in a 74-year-old ovarian cancer patient : Radiological features and considerations for preventing delayed diagnosis

enthalten in: Radiology case reports | 2024

von Saito, Y. | Yamaguchi, R. | Suzuki, T. | +7

5

Patient-Reported Outcomes in OlympiA : A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in gBRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Ganz, P. | Bandos, H. | Španić, T. | +43

6

Evaluating homologous recombination activity in tissues to predict the risk of hereditary breast and ovarian cancer and olaparib sensitivity

enthalten in: Scientific reports | 2024

von Motonari, T. | Yoshino, Y. | Haruta, M. | +8

7

Metastatic breast cancer with double heterozygosity for the BRCA1 and BRCA2 genes responding to olaparib : A case report

enthalten in: Oncology letters | 2024

von Shao, B. | Di, L.

8

Tolerability of Olaparib Combined with Abiraterone in Patients with Metastatic Castration-resistant Prostate Cancer : Further Results from the Phase 3 PROpel Trial

enthalten in: European urology oncology | 2024

von Saad, F. | Armstrong, A. | Oya, M. | +16

9

Docking and Molecular Dynamics Simulation Revealed the Potential Inhibitory Activity of Amygdalin in Triple-Negative Breast Cancer Therapeutics Targeting the BRCT Domain of BARD1 Receptor

enthalten in: Molecular biotechnology | 2024

von Chatterjee, P. | Karn, R. | Emerson, I. | +1

10

Pharmacokinetic drug-drug interaction between olaparib and apixaban : a case report

enthalten in: Cancer chemotherapy and pharmacology | 2024

von Berge, M. | Giraud, J. | De Percin, S. | +3

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[228]